Home :: How Nu Eyes Reverses Cataracts

How Nu Eyes Reverses Cataracts

How & Why Nu-Eyes™ Reverses Cataracts

eye cataract

How does N-Acetylcarnosine (Nu-Eyes™) actually work against cataracts?

Firstly, it is now known that a major contributing factor in the formation of cataract is oxidative damage. This means that cataract is the result of lipid peroxidative damage to the lens of the eye due in part to oxygen free radicals in the eye. Unchecked oxidation of the lipid (fat) component of membranes (electrons are stolen from cell membranes by free radicals) results in the damage of the lens of the eye. N-acetylcarnosine has also been found to be effective in preventing and breaking down advanced glycation end products (AGEs) that also contribute to the development of cataracts. AGEs form when excess sugars in the body are able to attach to proteins. The addition of these sugars causes structural changes in the molecules. The normally flexible molecules now become rigid and cross-linking occurs. The stiffening and cross-linking of cells lead to decreased cellular function. Diabetics are at an increased risk for damage caused by AGEs.

These destructive processes occur and advance as the natural anti-oxidant supply in the eye diminishes. Critical anti-oxidant supplies are continually being depleted from the eye in various disease states such as diabetes, various inflammatory conditions such as arthritis, viral loads, and vascular insufficiency, as well as many other conditions. Anti-oxidant supplies are also depleted while defending the body against damage from ultraviolet light and many chemical toxins.

Researchers recently learned that the healthy human eye contains high levels of the natural anti-oxidant carnosine. Interestingly the eyes of those suffering from degenerative ocular diseases such as cataracts were found to be grossly deficient in this essential ocular anti-oxidant.

The prime ingredient in Nu-Eyes™ is a form of the naturally occurring N-acetylcarnosine, a highly specific carrier of the di-peptide L-carnosine, safely delivering it into the aqueous humour of the eye (the fluid area inside the eye surrounding the lens). It is here that the L-carnosine becomes most active in its ability to act as a natural and highly effective anti-oxidant.

What is the difference between Carnosine,
L-Carnosine and N-Acetylcarnosine?

There are different forms of carnosine naturally found in the human body. The best known is the di-peptide L-Carnosine and much has been published as to its impressive anti-oxidant and anti-aging benefits. L-Carnosine was discovered around 1900 by another Russian scientist named W.S. Gulewich. A great deal has been learned about L-carnosine over the past century. N-acetylcarnosine is naturally found in the body and is a unique time release carrier form of L-carnosine. It is the acetylation of L-carnosine that makes N-acetylcarnosine suitable and stable in the eye. Unfortunately L-carnosine is not very lipid (fat) soluble and can not easily pass through the outer membranes of the eye. N-acetylcarnosine is lipid soluble and can pass easily into the eye where it then releases L-carnosine into the aqueous humour. When L-carnosine is applied topically to the eye, it is easily broken down by an enzyme on the surface of the eye called carnosinase and therefore is not substantially deliverable into the aqueous humour. Carnosinase breaks down L-carnosine into its constituent peptides, β-alanyl and L-histidine. Over time, L-histidine can be broken down to a chemical called histamine. You may have heard histamine mentioned when talking about allergic reactions. Histamine can actually damage the eye by promoting further oxidation reactions. L-carnosine by itself is not suitable for eye drop use as it is either ineffective or could even be damaging to some tissues over time.

The acetylated version of L-carnosine, N-acetylcarnosine makes it very stable and highly resistant to carnosinase. Additionally this stabilized compound protects against oxidative stress in the lipid phase of biological cellular membranes and in the aqueous environment by a gradual, time release of L-carnosine, thus maintaining a longer active therapeutic concentration of carnosine directly within the aqueous humour and the lens of the treated eye. The purity level of this particular N-acetylcarnosine is critical to its effectiveness.

Years of research were spent to identify a specific purity level of N-acetylcarnosine that would ensure both safety and optimal results. This purity level is critical and only the N-acetylcarnosine products with this specific clinically proven purity should be applied to the eyes. Only the Nu-Eyes™ N-acetylcarnosine formula was used in the clinical trials.


  1. Babizhayev, M. A., Deyev, A.I. Free radical oxidation of lipid and thiol groups in genesis of cataract. Biophysics, 1986; 31:119-125.
  2. Babizhayev, M.A., Deyev, A.I., Linberg, L.F. Lipid peroxidation as a possible cause of cataract.  Mech Ageing Dev, 1988; 44: 69-89.
  3. Babizhayev, M.A., Deyev, A.I. Lens opacity induced by lipid peroxidation products as a model of cataract associated with retinal disease. Biochim Biophys Acta, 1989; 1004: 124-133.
  4. Babizhayev, M.A. Antioxidant activity of L-carnosine, a natural histidine-containing di-peptide in crystalline lens. Biochem Biophys Acta, 1989; 1004: 363-371.
  5. Babizhayev, M.A., Bozzo Costa E "Composizioni farmaceutiche contenenti N-acetilcarnosina per il trattamento della cataratta." A61K gruppo 37/00 cap 20122 MI 15.10.1993. (Italian patent)
  6. Babizhayev, M. A., Bozzo Costa, E. Pharmaceutical compositions containing N-Acetylcarnosine for the treatment of cataract. European Patent PCT/EP 94/03340 10.10.1994 Ref. SCB 238 PCT.
  7. Babizhayev, M.A., Seguin M.C., Gueyene, J., Evstigneeva, R.P., Ageyeva, E.A., Zheltukhina, G.A. L-carnosine and carcinine act as natural antioxidants with hydroxyl-radical-scavenging and lipid peroxidase activities. Biochem J, 1994; 304: 509-516.
  8. Babizhayev, M. A., Yermakova, V.N., Sakina, N.L., Evstigneeva, R.P., Rozhkova, E.A., Zheltukhina, G.A. N-Acetylcarnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant. Clin Chim Acta, 1996; 254: 1-21.
  9. Babizhayev, M.A., Yermakova, V.N.,Deyev, A.I., Seguin, M.C. Imidazole-containing peptiomimetic NAC as a potent drug for the medicinal treatment of age-related cataract in humans. J. Anti-Aging Medicine, 2000; 2: 43-62.
  10. Babizhayev, M.A., Yermakova V.N., Semiletov. Y.A., Deyev, A.I.  The natural histidine-containing di-peptide N-acetylcarnosine as an antioxidant for ophthalmic use. Biochemistry(Moscow), 2000; 65: 588-598.
  11. Babizhayev, M.A., Deyev, A.I., Yermakova,V.N., Semiletov Y.A., Davydova N.G., Kurysheva, N.I., Zhokotskii, A.V., Goldman,  I.M. N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts. Peptides, 2001; 22: 979-94.
  12. Babizhayev, M. A., Deyev, A. I., Yermakova, V.N., Semiletov, Y.A., Davydova, N.G., Doroshenko, V.S., Zhukotskii, A.V., Goldman, I.M. Efficacy of N-acetylcarnosine in the treatment of cataracts.  Drugs R&D, 2002; 3(2): 87-103.
  13. Babizhayev, M. A., Deyev, A. I., Yermakova, V.N., Remenshchikov, V. V., Bours, J. Revival of lens transparency with N-acetylcarnosine.  Current Drug Therapy, 2006, 1:91-116.
  14. Baslow, M.H. Function of the N-acetyl-L-histidine system in the vertebrate eye. Evidence in support of a role as a molecular water pump. J Mol Neurosci, 1998; 10(3): 193-208.
  15. Boldyrev, A.A., Dupin, A.M., Babizhayev, M.A., Bunin, A.Ya.,  Severin, S.E. The antioxidative properties of carnosine, a natural histidine containing di-peptide. Biochem Intern, 1987; 15: 1105-1113.
  16. Boldyrev, A.A. Problems and perspectives in studying the biological role of carnosine. International Center for Biotechnology, Department of Biochemistry, Lomonosov, Moscow State University.
  17. Maichuk, IuF., Formaziuk, V.E., Sergienko, V.I. Development of carnosine eyedrops and assessing their efficacy in corneal diseases. Vestn Oftalmol 1997; 113(6): 27-31.
  18. Wang,A.M., Ma, C., Xie, Z. H., Shen,F. Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry, 2000; 65(7): 869-871.
  19. Wang, A.M., Ma, C, Xie, Z.H., Shen, F. Medical application of carnosine Department of Biochemistry and Neurobiology, Harbin Medical University, China.
  20. Yermakova, V.N., Babizhayev, M.A., Bunin, A.Y. Effect of L-carnosine on intraocular pressure. Bull Exp Biol and Med, 1988; 105(4): 451-453.
  21. Yuneva, M.O., Bulygina, E.R., Gallant, S.C., et al. Effect of carnosine on age-induced changes in senescence-accelerated mice. J Anti-Aging Medicine, 2; 1999: 337-342.